TY  - JOUR

T1  - Impact of Osilodrostat on Health‐Related Quality of Life in Cushing's Disease: Analysis of Patient‐Reported Outcomes From the Phase III LINC 3 and LINC 4 Clinical Trials

JO  - Clinical Endocrinology

UR  - https://doi.org/10.1111/cen.70166

PY  - 2026/06/01

AU  - Newell‐Price J

AU  - Biller BMK

AU  - Fleseriu M

AU  - Gueron B

AU  - Binowski G

AU  - Paćkowska A

AU  - Gadelha MR

ED  - 

DO  - DOI: 10.1111/cen.70166

PB  - Wiley

Y2  - 2026/06/21

ER  -